Relmada Therapeutics Stock Price History
RLMD Stock | USD 0.30 0 1.00% |
Below is the normalized historical share price chart for Relmada Therapeutics extending back to June 20, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Relmada Therapeutics stands at 0.30, as last reported on the 21st of March, with the highest price reaching 0.31 and the lowest price hitting 0.30 during the day.
If you're considering investing in Relmada Stock, it is important to understand the factors that can impact its price. Relmada Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0371, which implies the firm had a -0.0371 % return per unit of risk over the last 3 months. Relmada Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Relmada Therapeutics' Variance of 34.9, risk adjusted performance of (0.04), and Coefficient Of Variation of (1,740) to confirm the risk estimate we provide.
At present, Relmada Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 780.3 M, whereas Liabilities And Stockholders Equity is forecasted to decline to about 61 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price To Sales Ratio is forecasted to decline to 1,750. Relmada Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of October 2014 | 200 Day MA 2.1921 | 50 Day MA 0.3288 | Beta 0.646 |
Relmada |
Sharpe Ratio = -0.0371
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | RLMD |
Estimated Market Risk
5.87 actual daily | 52 52% of assets are less volatile |
Expected Return
-0.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Relmada Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Relmada Therapeutics by adding Relmada Therapeutics to a well-diversified portfolio.
Relmada Therapeutics Stock Price History Chart
There are several ways to analyze Relmada Stock price data. The simplest method is using a basic Relmada candlestick price chart, which shows Relmada Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | December 31, 2024 | 0.52 |
Lowest Price | February 28, 2025 | 0.26 |
Relmada Therapeutics March 21, 2025 Stock Price Synopsis
Various analyses of Relmada Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Relmada Stock. It can be used to describe the percentage change in the price of Relmada Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Relmada Stock.Relmada Therapeutics Price Rate Of Daily Change | 1.01 | |
Relmada Therapeutics Accumulation Distribution | 5,484 | |
Relmada Therapeutics Price Daily Balance Of Power | 0.30 |
Relmada Therapeutics March 21, 2025 Stock Price Analysis
Relmada Stock Price History Data
The price series of Relmada Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 0.26 with a coefficient of variation of 17.53. The price distribution for the period has arithmetic mean of 0.35. The median price for the last 90 days is 0.35. The company completed stock split (1:4) on 30th of September 2019. Relmada Therapeutics had dividends distributed to its stock-holders on 2019-09-30.Open | High | Low | Close | Volume | ||
03/20/2025 | 0.30 | 0.31 | 0.30 | 0.30 | 169,999 | |
03/19/2025 | 0.30 | 0.31 | 0.28 | 0.30 | 216,489 | |
03/18/2025 | 0.29 | 0.30 | 0.29 | 0.30 | 146,973 | |
03/17/2025 | 0.29 | 0.30 | 0.28 | 0.29 | 282,078 | |
03/14/2025 | 0.28 | 0.30 | 0.27 | 0.29 | 1,050,181 | |
03/13/2025 | 0.26 | 0.28 | 0.26 | 0.27 | 285,195 | |
03/12/2025 | 0.27 | 0.28 | 0.26 | 0.27 | 201,765 | |
03/11/2025 | 0.28 | 0.29 | 0.27 | 0.27 | 278,946 | |
03/10/2025 | 0.28 | 0.29 | 0.27 | 0.27 | 341,975 | |
03/07/2025 | 0.27 | 0.29 | 0.26 | 0.29 | 524,631 | |
03/06/2025 | 0.26 | 0.27 | 0.25 | 0.27 | 440,091 | |
03/05/2025 | 0.26 | 0.27 | 0.26 | 0.26 | 275,174 | |
03/04/2025 | 0.25 | 0.26 | 0.24 | 0.26 | 488,673 | |
03/03/2025 | 0.26 | 0.26 | 0.24 | 0.26 | 447,424 | |
02/28/2025 | 0.27 | 0.28 | 0.26 | 0.26 | 342,756 | |
02/27/2025 | 0.27 | 0.28 | 0.26 | 0.28 | 384,808 | |
02/26/2025 | 0.28 | 0.29 | 0.26 | 0.27 | 254,873 | |
02/25/2025 | 0.28 | 0.29 | 0.26 | 0.28 | 323,660 | |
02/24/2025 | 0.29 | 0.29 | 0.28 | 0.29 | 414,223 | |
02/21/2025 | 0.31 | 0.32 | 0.29 | 0.30 | 774,628 | |
02/20/2025 | 0.33 | 0.33 | 0.31 | 0.31 | 606,271 | |
02/19/2025 | 0.32 | 0.34 | 0.31 | 0.33 | 444,141 | |
02/18/2025 | 0.35 | 0.35 | 0.32 | 0.33 | 705,433 | |
02/14/2025 | 0.32 | 0.36 | 0.31 | 0.33 | 1,278,618 | |
02/13/2025 | 0.30 | 0.35 | 0.29 | 0.33 | 1,280,526 | |
02/12/2025 | 0.29 | 0.31 | 0.28 | 0.30 | 710,691 | |
02/11/2025 | 0.30 | 0.30 | 0.28 | 0.29 | 958,237 | |
02/10/2025 | 0.30 | 0.31 | 0.29 | 0.31 | 1,252,277 | |
02/07/2025 | 0.32 | 0.34 | 0.29 | 0.31 | 2,945,339 | |
02/06/2025 | 0.48 | 0.49 | 0.33 | 0.34 | 26,026,020 | |
02/05/2025 | 0.33 | 0.39 | 0.32 | 0.38 | 1,125,734 | |
02/04/2025 | 0.33 | 0.34 | 0.32 | 0.34 | 197,381 | |
02/03/2025 | 0.34 | 0.35 | 0.31 | 0.34 | 541,500 | |
01/31/2025 | 0.35 | 0.37 | 0.34 | 0.35 | 342,326 | |
01/30/2025 | 0.37 | 0.37 | 0.34 | 0.35 | 464,396 | |
01/29/2025 | 0.36 | 0.38 | 0.35 | 0.36 | 646,328 | |
01/28/2025 | 0.36 | 0.37 | 0.35 | 0.36 | 212,178 | |
01/27/2025 | 0.38 | 0.39 | 0.34 | 0.37 | 444,265 | |
01/24/2025 | 0.37 | 0.40 | 0.37 | 0.39 | 312,635 | |
01/23/2025 | 0.39 | 0.39 | 0.38 | 0.38 | 135,348 | |
01/22/2025 | 0.39 | 0.39 | 0.36 | 0.39 | 642,350 | |
01/21/2025 | 0.37 | 0.38 | 0.36 | 0.37 | 272,595 | |
01/17/2025 | 0.40 | 0.40 | 0.36 | 0.37 | 208,625 | |
01/16/2025 | 0.38 | 0.41 | 0.36 | 0.38 | 609,000 | |
01/15/2025 | 0.40 | 0.41 | 0.39 | 0.40 | 264,599 | |
01/14/2025 | 0.40 | 0.44 | 0.39 | 0.40 | 420,087 | |
01/13/2025 | 0.42 | 0.44 | 0.38 | 0.40 | 532,366 | |
01/10/2025 | 0.45 | 0.45 | 0.40 | 0.41 | 559,536 | |
01/08/2025 | 0.46 | 0.48 | 0.44 | 0.45 | 744,103 | |
01/07/2025 | 0.44 | 0.49 | 0.43 | 0.47 | 881,517 | |
01/06/2025 | 0.47 | 0.48 | 0.44 | 0.44 | 1,292,504 | |
01/03/2025 | 0.44 | 0.48 | 0.43 | 0.47 | 942,258 | |
01/02/2025 | 0.52 | 0.52 | 0.45 | 0.45 | 1,865,095 | |
12/31/2024 | 0.48 | 0.53 | 0.42 | 0.52 | 2,467,012 | |
12/30/2024 | 0.39 | 0.49 | 0.39 | 0.46 | 3,339,476 | |
12/27/2024 | 0.36 | 0.41 | 0.36 | 0.38 | 1,246,990 | |
12/26/2024 | 0.36 | 0.37 | 0.35 | 0.36 | 338,736 | |
12/24/2024 | 0.36 | 0.37 | 0.34 | 0.36 | 609,998 | |
12/23/2024 | 0.39 | 0.40 | 0.35 | 0.38 | 542,264 | |
12/20/2024 | 0.34 | 0.38 | 0.34 | 0.36 | 425,048 | |
12/19/2024 | 0.35 | 0.37 | 0.34 | 0.35 | 673,407 |
About Relmada Therapeutics Stock history
Relmada Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Relmada is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Relmada Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Relmada Therapeutics stock prices may prove useful in developing a viable investing in Relmada Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 34.6 M | 36.3 M | |
Net Loss | -141.3 M | -148.4 M |
Relmada Therapeutics Quarterly Net Working Capital |
|
Relmada Therapeutics Stock Technical Analysis
Relmada Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
All Next | Launch Module |
Relmada Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Relmada Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Relmada Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Relmada to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.27) | |||
Total Risk Alpha | 0.1492 | |||
Treynor Ratio | (0.32) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Relmada Stock analysis
When running Relmada Therapeutics' price analysis, check to measure Relmada Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relmada Therapeutics is operating at the current time. Most of Relmada Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relmada Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relmada Therapeutics' price. Additionally, you may evaluate how the addition of Relmada Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |